A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects
Conditions: Healthy Interventions: Drug: ABBV-CLS-7262; Drug: ABBV-CLS-7262; Drug: Placebo; Drug: Moxifloxacin 400mg Sponsors: Calico Life Sciences LLC; AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II
Conditions: Bacterial Keratitis Interventions: Drug: Difluprednate Ophthalmic; Drug: Rose Bengal; Drug: Moxifloxacin Ophthalmic Sponsors: University of California, San Francisco; Stanford University; Aravind Eye Care System; Federal University of S ão Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements
Conditions: Healthy Volunteers Interventions: Drug: TAK-279; Drug: TAK-279 Placebo; Drug: Moxifloxacin; Drug: Moxifloxacin Placebo Sponsors: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Shortened Regimen for Drug-susceptible TB in Children
Conditions: Tuberculosis; Tuberculosis, Pulmonary; Tuberculosis, Lymph Node; Mycobacterium Tuberculosis Interventions: Drug: Isoniazid; Drug: Rifampin; Drug: Pyrazinamide; Drug: Ethambutol; Drug: Rifapentine; Drug: Moxifloxacin Sponsors: Johns Hopkins University; United States Agency for International Development (USAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in Healthy Participants
Conditions: Healthy Interventions: Drug: Pirtobrutinib; Drug: Placebo; Drug: Moxifloxacin Sponsors: Eli Lilly and Company; Loxo Oncology, Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute Appendicitis
Conditions: Uncomplicated Acute Appendicitis Interventions: Drug: Moxifloxacin 400mg; Other: Placebo Sponsors: Turku University Hospital; Tampere University Hospital; Oulu University Hospital; Kuopio University Hospital; Pori Central Hospital; Jyv äskylä Central Hospital; Mikkeli Central Hospital; Seinajoki Central Hospital; Päijänne Tavastia Central Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity
Conditions: Overweight; Obesity Interventions: Drug: BI 456906; Drug: Placebo to BI 456906; Drug: Moxifloxacin; Drug: Placebo to moxifloxacin Sponsors: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positive Control, in Healthy Participants
Conditions: Healthy Participants Interventions: Drug: Baxdrostat; Drug: Placebo; Drug: Moxifloxacin Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Conditions: Community-acquired Bacterial Pneumonia Interventions: Drug: Omadacycline; Drug: Moxifloxacin Sponsors: Zai Lab (Hong Kong), Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects
Conditions: Cardiac Repolarization in Healthy Subjects Interventions: Drug: Carbidopa capsule; Drug: Moxifloxacin Tablets, USP; Drug: Placebo Sponsors: Impax Laboratories, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
Conditions: Pulmonary Tuberculosis Interventions: Drug: GSK3036656; Drug: BTZ-043; Drug: Bedaquiline (B); Drug: Delamanid (D); Drug: Pretomanid (Pa); Drug: Moxifloxacin (M); Drug: Linezolid (L); Drug: Pyrazinamide (Z); Drug: Rifampicin (R); Drug: Isoniazid (H); Drug: Ethambutol (E) Sponsors: University College, London; Radboud University Medical Center; London School of Hygiene and Tropical Medicine; University of Oxford; Research Center Borstel; Lygature; TASK Applied Science; Vita-Salute San Raffaele University; Helmholtz Zentrum Munchen; KNCV Tuberculosis Foundation; Critical Path Institute; European Lung Foundation; In...
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities
Conditions: Healthy Interventions: Drug: BI 1015550; Drug: Moxifloxacin; Drug: Placebo Sponsors: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis ：Contizolid and Dlamanid Cohort
Conditions: Pulmonary Tuberculosis; Rifampicin-resistant Tuberculosis Interventions: Drug: Bedaquiline; Drug: Delamanid; Drug: Contezolid; Drug: Levofloxacin; Drug: Moxifloxacin; Drug: Clofazimine; Drug: Linezolid; Drug: Cycloserine; Drug: Prothionamide; Drug: Pyrazinamide; Drug: Para-Aminosalicylic Acid; Drug: Ethambutol Sponsors: Beijing Chest Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety
Conditions: Healthy Interventions: Drug: Iclepertin; Drug: Iclepertin Placebo; Drug: Moxifloxacin; Drug: Moxifloxacin Placebo Sponsors: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials
Microbiome Effect of Omadacycline on Healthy Volunteers
Condition: Healthy Volunteers Interventions: Drug: Omadacycline; Drug: Vancomycin Pill; Drug: Moxifloxacin Sponsors: University of Houston; Paratek Pharmaceuticals Inc Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
